Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 August 2008, Vol. 112, No. 3, pp. 551-559.
Prepublished online as a Blood First Edition Paper on May 27, 2008; DOI 10.1182/blood-2007-11-125930.


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Methods and Figures
Right arrow All Versions of this Article:
blood-2007-11-125930v1
112/3/551    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Guo, F.
Right arrow Articles by Weih, F.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guo, F.
Right arrow Articles by Weih, F.
Related Collections
Right arrow Hematopoiesis and Stem Cells
Right arrow Immunobiology
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

HEMATOPOIESIS AND STEM CELLS

Lack of nuclear factor-{kappa}B2/p100 causes a RelB-dependent block in early B lymphopoiesis

Feng Guo1, Simone Tänzer1, Meinrad Busslinger2, and Falk Weih1,3

1 Research Group Immunology, Leibniz-Institute for Age Research—Fritz-Lipmann-Institute, Jena, Germany; 2 Research Institute of Molecular Pathology, Vienna, Austria; and 3 Friedrich-Schiller-University, Jena, Germany

Nuclear factor-{kappa}B (NF-{kappa}B) transcription factors regulate B-cell development and survival. However, whether they also have a role during early steps of B-cell differentiation is largely unclear. Here, we show that constitutive activation of the alternative NF-{kappa}B pathway in p100–/– knockin mice resulted in a block of early B-cell development at the transition from the pre–pro-B to the pro–B-cell stage due to enhanced RelB activity. Expression of the essential B-cell transcription factors EBF and in particular Pax5 was reduced in p100–/– B-cell precursors in a RelB-dependent manner, resulting in reduced mRNA levels of B lineage-specific genes. Moreover, enhanced RelB function in p100–/– B-cell precursors was accompanied by increased expression of B lineage–inappropriate genes, such as C/EBP{alpha}, correlating with a markedly increased myeloid differentiation potential of p100–/– progenitor B cells. Ectopic expression of Pax5 in hematopoietic progenitors restored early B-cell development in p100–/– bone marrow, suggesting that impaired early B lymphopoiesis in mice lacking the p100 inhibitor may be due to down-regulation of Pax5 expression. Thus, tightly controlled p100 processing and RelB activation is essential for normal B lymphopoiesis and lymphoid/myeloid lineage decision in bone marrow.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2008 by American Society of Hematology         Online ISSN: 1528-0020